Cargando…
Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma
Glioblastoma (GBM) is an aggressive and incurable tumor of the brain with limited treatment options. Current first-line standard of care is the DNA alkylating agent temozolomide (TMZ), but this treatment strategy adds only ~4 months to median survival due to the rapid development of resistance. Whil...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940876/ https://www.ncbi.nlm.nih.gov/pubmed/29740146 http://dx.doi.org/10.1038/s41598-018-25588-1 |
_version_ | 1783321176023498752 |
---|---|
author | Tiek, D. M. Rone, J. D. Graham, G. T. Pannkuk, E. L. Haddad, B. R. Riggins, R. B. |
author_facet | Tiek, D. M. Rone, J. D. Graham, G. T. Pannkuk, E. L. Haddad, B. R. Riggins, R. B. |
author_sort | Tiek, D. M. |
collection | PubMed |
description | Glioblastoma (GBM) is an aggressive and incurable tumor of the brain with limited treatment options. Current first-line standard of care is the DNA alkylating agent temozolomide (TMZ), but this treatment strategy adds only ~4 months to median survival due to the rapid development of resistance. While some mechanisms of TMZ resistance have been identified, they are not fully understood. There are few effective strategies to manage therapy resistant GBM, and we lack diverse preclinical models of acquired TMZ resistance in which to test therapeutic strategies on TMZ resistant GBM. In this study, we create and characterize two new GBM cell lines resistant to TMZ in vitro, based on the 8MGBA and 42MGBA cell lines. Analysis of the TMZ resistant (TMZres) variants in conjunction with their parental, sensitive cell lines shows that acquisition of TMZ resistance is accompanied by broad phenotypic changes, including increased proliferation, migration, chromosomal aberrations, and secretion of cytosolic lipids. Importantly, each TMZ resistant model captures a different facet of the “go” (8MGBA-TMZres) or “grow” (42MGBA-TMZres) hypothesis of GBM behavior. These in vitro model systems will be important additions to the available tools for investigators seeking to define molecular mechanisms of acquired TMZ resistance. |
format | Online Article Text |
id | pubmed-5940876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-59408762018-05-14 Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma Tiek, D. M. Rone, J. D. Graham, G. T. Pannkuk, E. L. Haddad, B. R. Riggins, R. B. Sci Rep Article Glioblastoma (GBM) is an aggressive and incurable tumor of the brain with limited treatment options. Current first-line standard of care is the DNA alkylating agent temozolomide (TMZ), but this treatment strategy adds only ~4 months to median survival due to the rapid development of resistance. While some mechanisms of TMZ resistance have been identified, they are not fully understood. There are few effective strategies to manage therapy resistant GBM, and we lack diverse preclinical models of acquired TMZ resistance in which to test therapeutic strategies on TMZ resistant GBM. In this study, we create and characterize two new GBM cell lines resistant to TMZ in vitro, based on the 8MGBA and 42MGBA cell lines. Analysis of the TMZ resistant (TMZres) variants in conjunction with their parental, sensitive cell lines shows that acquisition of TMZ resistance is accompanied by broad phenotypic changes, including increased proliferation, migration, chromosomal aberrations, and secretion of cytosolic lipids. Importantly, each TMZ resistant model captures a different facet of the “go” (8MGBA-TMZres) or “grow” (42MGBA-TMZres) hypothesis of GBM behavior. These in vitro model systems will be important additions to the available tools for investigators seeking to define molecular mechanisms of acquired TMZ resistance. Nature Publishing Group UK 2018-05-08 /pmc/articles/PMC5940876/ /pubmed/29740146 http://dx.doi.org/10.1038/s41598-018-25588-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Tiek, D. M. Rone, J. D. Graham, G. T. Pannkuk, E. L. Haddad, B. R. Riggins, R. B. Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma |
title | Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma |
title_full | Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma |
title_fullStr | Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma |
title_full_unstemmed | Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma |
title_short | Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma |
title_sort | alterations in cell motility, proliferation, and metabolism in novel models of acquired temozolomide resistant glioblastoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940876/ https://www.ncbi.nlm.nih.gov/pubmed/29740146 http://dx.doi.org/10.1038/s41598-018-25588-1 |
work_keys_str_mv | AT tiekdm alterationsincellmotilityproliferationandmetabolisminnovelmodelsofacquiredtemozolomideresistantglioblastoma AT ronejd alterationsincellmotilityproliferationandmetabolisminnovelmodelsofacquiredtemozolomideresistantglioblastoma AT grahamgt alterationsincellmotilityproliferationandmetabolisminnovelmodelsofacquiredtemozolomideresistantglioblastoma AT pannkukel alterationsincellmotilityproliferationandmetabolisminnovelmodelsofacquiredtemozolomideresistantglioblastoma AT haddadbr alterationsincellmotilityproliferationandmetabolisminnovelmodelsofacquiredtemozolomideresistantglioblastoma AT rigginsrb alterationsincellmotilityproliferationandmetabolisminnovelmodelsofacquiredtemozolomideresistantglioblastoma |